REUTERS EVENTS: Pharma Japan 2024
Welcome to the era of unprecedented healthcare innovation. Join the most influential annual forum for Japanese pharma leaders for your guided tour.      
Reuters Events Pharma Japan (September 25-26, 2024, Tokyo) has been the cornerstone for industry leaders and innovators.  Join industry-leading executive attendees (from across Commercial, Sales, Marketing/Digital, IT, Medical, Patient Engagement, Market Access, RWE and Clinical) on their yearly journey to fuel change. 

With an impressive history spanning 18 years, the annual Reuters Events: Pharma Japan invites you to join this celebrated event, renowned as the premier gathering for pioneers, thinkers, and changemakers in the pharmaceutical industry. Here, you will not only discuss the future of healthcare but actively participate in shaping it. Come innovate, forge valuable relationships, and be part of a community that is at the forefront of healthcare transformation. Engage in pivotal discussions, gain unparalleled insights, and help lead the charge in redefining the healthcare landscape.

Our session structure in 2024

  • Oue two day long sessions offer a comprehensive exploration of the pharmaceutical industry, providing a complete panorama from core concepts to cutting-edge advancements

4 Pillars of Our Conference

  1. AI and Data Enablement: Leverage AI for deeper customer insights and streamline team operations for heightened efficiency
  2. Medical-Driven Collaboration: Enhance synergy across teams for better outcomes
  3. Customer Excellence & Omnichannel Strategies: Craft seamless communication paths
  4. Patient Experience: Elevate care through innovation

Directions of Our Keynote

  1. Future of Pharma – Create an Organization Capable of Transforming: Taking innovation to new heights on the strength of our existing competencies
  2. The Future of Health for the People: Rethink the value that can be provided from human health perspectives and position pharmaceuticals in people's lives
Passionate Presenters in 2024 include:
Unlock the Future of Customer Excellence: A Dynamic Roundtable Discussion
In today's fast-evolving information landscape, understanding customer insights is becoming increasingly complex. Join us for an enlightening roundtable discussion where we will explore the future of customer excellence. Delve into three visionary directions that will shape the next generation of customer engagement and success. Don't miss this opportunity to redefine excellence in customer interactions!
Already confirmed topics includes:

Redefine and realign the roles of commercial excellence and IT to achieve data-backed engagement strategies

We aim to form a common understanding of the use of technology, data, and AI in the pharmaceutical industry by learning from case studies of data-driven promotions and exploring actionable strategies to modernize customer communication in line with current advancements and trends.

Enhance omni-channel engagement through digital co-creation 
To effectively enhance omni-channel engagement, it is crucial to not only integrate and leverage both internal and external data and systems but also to establish a collaborative digital creation process. This involves fostering a synergy between frontline staff and digital tools, and developing mechanisms for digital utilization that can bridge any gaps in experience levels. Our session will concentrate on omni-channel strategies and include a roundtable discussion on initiatives aimed at further improving omni-channel engagement.

Explore exit strategies for long-term listed products
We are dedicated to examining the necessary environment and infrastructure required to guarantee a consistent supply of NHI products that may not be profitable, yet are crucial in a patient-centered value system. Let's discuss strategies to deliver enduring patient value in a truly sustainable way.
New! Interactive Hackathon at Reuters Pharma Japan
Unleash Your Creativity in Our Exciting 2-Hour Idea Sprint!
Prepare to dive into a hyper-interactive brainstorming session that promises to light up your innovative spirit. This is your opportunity to shine, share your ideas, and collaborate on transforming concepts into actionable plans. Don't miss out on this unique chance to push the boundaries of creativity and innovation. Join us to make a difference and leave a mark with your ideas! This exciting 120-minute participatory session is divided into two audience groups:

Hackathon 1: Building an Ecosystem - This session focuses on fostering smooth collaboration between stakeholders to shape a new era of healthcare, emphasizing AI and data use. Participants will include specialists in Medical, Real-World Data (RWD), Evidence Generation, Clinical, Research, and Development.

Topics include:

Leverage Real-World Data to generate evidence and increase value in a collaborative era
This session will focus on the opportunities and challenges of utilizing real-world data (RWD) to generate evidence and create value, particularly in an environment where traditional organizational silos are being dismantled. We will explore strategies for effective data integration, analysis, and application across different sectors within the pharma industry.

The importance of projectisation from the perspective of the potential uses of RWDs
RWD has a wide range of potential applications, but are we limiting its potential by limiting its purpose?
We invite Mr Togo from Pfizer and Mr Saito from Nippon Boehringer Ingelheim, who are leading the use of RWD by promoting projects with multiple approaches, as leaders to explore the importance and value of voicing your own opinion and making a project out of it. Join us to consider what approaches and actions can be taken to utilise the data collected in a way that benefits patients.

An overview and better understanding of true ‘patient-centredness’ from a sociological perspective
Health support apps might be more widely disseminated and contribute to society if they were not approved as medical devices. Also, although correct diagnosis is an important medical treatment for ‘cure’, do patients really want to be cured, or are they discouraged by the stigma of being ‘not normal’? What is medical care? Discussing the essence of what it means to be ‘for the patient’.

Overcome the challenges in evidence generation by streamlining medical planning and research execution process to maximize the value of the evidence

Timely publication of evidence is crucial, yet the process frequently experiences delays. We will explore strategies to streamline the evidence-generation process and expedite value enhancement.

Data-Driven Strategic Innovation: From Data to Value Creation in Pharma
Currently, pharmaceutical industry is undergoing unprecedented rapid changes, driven by digital transformation. By leveraging digital technologies and implementing data management practices based on the FAIR (Findable, Accessible, Interoperable, Reusable) principles, it is possible to effectively utilize data across various departments. This allows for more accurate decision making and the creation of new value through the use of AI and big data analysis. This session will focus on data-driven strategies that leverage AI and other advanced technologies for data utilization. We will discuss how integrating data generated from different departments and promoting a comprehensive digital strategy across the entire organization can lead to the creation of new value.

Hackathon 2: Customer Excellence - This session focuses on customer engagement, omni-channel strategy, AI and data to grow and succeed across the industry in co-creation and competition to refine customer excellence in the future. The event will include specialists from Marketing, Commercial Excellence, Sales, Data, and Digital.

Topics include:

Synergize co-creation and competition: craft superior marketing strategies in pharmaceutical touchpoints
The HCP working practices requires us communication to take more account of customers' time. One of the touchpoints is touchpoints. Where should the line be drawn between partnerships between your company and others, whether paid or owned media is better, and whether it is better to collaborate or compete as an industry? Think about strategies for maximum results in the new environment.

Tailor content for HCPs: strategies for selecting and sequencing content combined with effective lifecycle management
This session will explore how to tailor and manage content specifically for healthcare professionals. We will delve into strategies for selecting the right content, sequencing it in a way that maximizes engagement and retention, and managing the content lifecycle to ensure relevance and effectiveness.

We look forward to seeing your brilliant contributions. Let’s innovate together! 
Kind regards,

Kana
ORDER YOUR BROCHURE NOW  

Be the first to see the agenda, speaker line-up and exclusive discounts.  

Reuters Events will use this information to contact you about relevant content, products, and services. You may unsubscribe at any time. For more information, check out our Privacy Policy: https://www.thomsonreuters.com/en/privacy-statement.html.

Kana Chia
Head of Japan
Pharma
Reuters Events
 
Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.